Prostate Cancer
Prostate specific antigen test has appreciable false positive rate
Published in Clinical Oncology Week, August 25th, 2003
"Although prostate specific antigen (PSA) is widely used in the discrimination of benign prostatic hyperplasia (BPH) and prostate cancer, its diagnostic value is controversial due to an appreciable false positive rate," scientists in Turkey report.
"In the present study, we compared a recently introduced assay method, equimolar PSA measurement, to nonequimolar PSA measurement and also determined the diagnostic value of percent free PSA with changing total PSA (tPSA) measurements," wrote R. Onur and colleagues, University of Firat, Firat Medical Center.
"Between...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Cervical Cancer
Inadequate Pap smears may be associated with increased risk - Metastasis
Patients survive incurable disease longer with new treatment - Cancer Pain
Panel calls for greater attention to patients' pain, depression, and fatigue - Gastric Cancer
Micrometastatic sentinel node detection by laparoscopy and histology may aid prognosis - Radiation Exposure
Urinary bladder lesions from low-dose radiation from Chernobyl leads to cancer - Acute Myeloid Leukemia
Mutation may contribute to AML - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
